CCR5 antagonists for the treatment of HIV

ISSN： 2195-2175

Source： PHARMAKON, Vol.2, Iss.4, 2014-07, pp. : 277-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Novel CCR5 antagonists for the treatment of HIV infection: a review of compounds patented in 2006 – 2008

By Yang Hanbiao Rotstein David M

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 325-354

Informa Healthcare

Access to resources Recommend Favorite

CCR5 antagonists the long-term solution for HIV?

Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Treatment of HIV infection with the CCR5 antagonist maraviroc

By Kromdijk Wiete Huitema Alwin DR Mulder Jan Willem

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1215-1223

Informa Healthcare

Access to resources Recommend Favorite

Medicinal Chemistry of Small Molecule CCR5 Antagonists for Blocking HIV-1 Entry: A Review of Structural Evolution

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1515-1538

Bentham Science Publishers

Access to resources Recommend Favorite

Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2041-2062

Bentham Science Publishers

Access to resources Recommend Favorite